TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 5 | 5 | -11 | -22 | -29 | 0 | -10 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/26/19 16:54 | 2/4/19 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Cory David A | CA | DO | P,CEO | P | 4 | 11.26 | 0 | 0 | 0 | 96 | D | |||||||||||||||
2/6/19 19:23 | 2/4/19 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Cory David A | CA | DO | P,CEO | P | 3 | 14.13 | 0 | 0 | 0 | 89 | D | |||||||||||||||
8/19/16 19:15 | 8/18/16 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Cory David A | CA | DO | P,CEO | P | 25 | 15.70 | 1 | 2 | 2 | 89 | D | -91 | -1 | 14 | -21 | -15 | -19 | -17 | -12 | 5 | 5 | -11 | -22 | -29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |